CardioLogs ECG Analysis Platform vs SENSICARDIAC

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 70/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by CardioLogs (acquired by Philips in 2021)
VS
by Diacoustic Medical Devices (Pty) Ltd.

AI Verdict

While both tools leverage AI and cloud technology for cardiac diagnostics, they focus on distinct aspects of heart health. CardioLogs ECG Analysis Platform is designed for detecting arrhythmias from ECG data, whereas SENSICARDIAC specializes in classifying heart murmurs from electronic stethoscope input. Therefore, CardioLogs would be chosen for rhythm disorder analysis, while SENSICARDIAC would be selected for auscultation-based murmur detection.

Choose CardioLogs ECG Analysis Platform if…

Choose CardioLogs ECG Analysis Platform if your practice requires comprehensive and automated arrhythmia detection across a wide range of cardiac monitoring devices. This platform is ideal for efficiently processing large volumes of ECG data from Holters, smartwatches, or ECG patches to quickly identify various arrhythmias like AFib and VT, streamlining diagnostic workflows.

View CardioLogs ECG Analysis Platform →

Choose SENSICARDIAC if…

Choose SENSICARDIAC if your primary need is AI-powered heart murmur detection and classification, especially when utilizing electronic stethoscopes in a clinical or telehealth setting. This tool excels at helping physicians quickly differentiate between pathological and physiological murmurs during auscultation, thereby reducing unnecessary specialist referrals and enhancing initial cardiac screenings.

View SENSICARDIAC →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature CardioLogs ECG Analysis Platform SENSICARDIAC
Deployment Cloud-based SensiCardiac is a software package running on a Windows PC that interfaces with compatible electronic stethoscopes. SensiCardiac Mobi runs on a mobile device (iPhone 4S or later) and interfaces with a hosted Linux server environment. The related Telesensi platform operates entirely in the browser.
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

CardioLogs ECG Analysis Platform

CardioLogs offers broader multi-device compatibility, including consumer wearables, and explicit EHR integration, which streamlines the entire workflow from data acquisition to reporting. Its cloud-based platform ensures accessibility and continuous updates, contributing to a consistently user-friendly experience, as confirmed by general usability tests.

Clinical Value

CardioLogs ECG Analysis Platform

CardioLogs has a more robust and extensive body of clinical validation, with numerous peer-reviewed publications demonstrating high accuracy, significant reduction in analysis time, and improved detection rates for various arrhythmias across adult and pediatric populations. Its FDA clearance was also among the first for deep learning in ECG analysis, with studies showing a 42% reduction in Holter analysis time and a 10x reduction in AF false positives.

Pricing & Value

CardioLogs ECG Analysis Platform

CardioLogs offers a more transparent and predictable 'pay per ECG regardless of the number of users' pricing model, which can be advantageous for budgeting and understanding costs based on usage volume. SENSICARDIAC's pricing details are not publicly available, making it difficult to assess its value proposition.

Enterprise Readiness

CardioLogs ECG Analysis Platform

Being a Philips solution, CardioLogs benefits from a robust enterprise infrastructure, including ISO/IEC 27001 certified AWS hosting, explicit EHR integration capabilities via Philips IntelliBridge Enterprise, and a global support network. Its cloud-based SaaS model and vendor neutrality further enhance its scalability and readiness for large-scale deployments.

Innovation

CardioLogs ECG Analysis Platform

CardioLogs pioneered the use of deep neural networks for ECG analysis, receiving the first FDA clearance for such a solution, and was recognized with a Frost & Sullivan New Product Innovation Award. Its multi-device compatibility, including smartwatches, and ability to reduce inconclusive results from these devices demonstrate significant innovation in data source integration and AI application.

Support & Docs

CardioLogs ECG Analysis Platform

CardioLogs, backed by Philips, offers clearly defined support channels, including a dedicated support center, product manuals, and technical support accessible through its platform. The explicit mention of 24/7 customer support and training indicates a more comprehensive support ecosystem.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature CardioLogs ECG Analysis Platform SENSICARDIAC
Company Cardiologs Technologies (now part of Philips) DIACOUSTIC MEDICAL (PTY)
Primary AI Function AI-Powered ECG Analysis (Deep Neural Networks) AI-powered heart murmur detection
Key Integrations/Compatibility Multi-Device Compatibility (Holter, smartwatches, ECG patches) Integration with electronic stethoscopes (e.g., 3M Littmannu00ae 3200)
Specialties Cardiology, Emergency Medicine, Internal Medicine Cardiology, Internal Medicine, Pediatrics
Data Security Data Encryption & Secure Hosting (ISO/IEC 27001 certified AWS servers) Not specified

Videos

Demos, reviews, and walkthroughs featuring CardioLogs ECG Analysis Platform and SENSICARDIAC.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

AI Tool Finder
AI-powered search. Results may not be comprehensive.